The company plans to start studies to show that its orally dissolving version of escitalopram oxalate works the same as Lexapro so that MonoSol Rx can submit the drug for marketing approval in the ...

TORONTO, ONTARIO and WARREN, NEW JERSEY--(Marketwired - Apr 4, 2016) - Cynapsus Therapeutics Inc. ("Cynapsus" or the "Company") (CYNA)(CTH.TO), and MonoSol Rx LLC ("MonoSol Rx") today announced that ...

MonoSol Rx is on a roll. During the span of a month this summer, the tiny Warren-based company announced that two of its drugmaker partners had received regulatory approval to sell reformulated ...

Specialty pharmaceutical company BioDelivery Sciences International (NASDAQ:BDSI) can now claim patent victories against all three patent challenges levied by a rival in a long-running patent dispute.

WARREN, N.J. and BALERNA, Switzerland, July 7 MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in film pharmaceutical products, in collaboration with APR ...

WARREN, N.J., Feb. 21 MonoSol Rx, a drug delivery companyspecializing in dissolving thin film pharmaceutical products, today announcedthat it has successfully completed a pilot clinical study for its ...

MonoSol, a drug delivery developer based in Warren, N.J., has received $20 million in financing, which includes the conversion of a year-old $10 million bridge loan. Ed Bass Group led the financing ...

Click to share on Facebook (Opens in new window) Click to share on X (Opens in new window) Click to print (Opens in new window) Click to email a link to a friend (Opens in new window) MonoSol sold its ...

- Strengthening Intellectual Property for Sublingual Delivery of Apomorphine to Treat OFF Episodes in Parkinson`s Disease Patients - TORONTO and WARREN, N.J., April 04, 2016 (GLOBE NEWSWIRE) ...